Strategies of Manipulating BMP Signaling in Microgravity to Prevent Bone Loss

Vitamins and Hormones

Volumn 99, Issue , 2015, Pages 249-272

  Siamwala, Jamila H ^a   Rajendran, Saranya ^b   Chatterjee, Suvro ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ANNA UNIVERSITY   (India)

Author keywords

Angiogenesis; Bipotential murine oval liver stem cells; Bone morphogenetic proteins; Bone perfusion; Microgravity; Random positioning machine; Space

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ANIMAL; BONE; BONE DENSITY; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; STEM CELL; WEIGHTLESSNESS;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; HUMANS; MICE; SIGNAL TRANSDUCTION; STEM CELLS; WEIGHTLESSNESS;

EID: 84932156863     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.vh.2015.05.004     Document Type: Chapter

References (102)

1. Abe E., Marians R.C., Yu W., Wu X.B., Ando T., Li Y., et al. TSH is a negative regulator of skeletal remodeling. Cell 2003, 115(2):151-162.
2. Abreu J.G., Ketpura N.I., Reversade B., De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nature Cell Biology 2002, 4(8):599-604. 10.1038/ncb826.
3. Ahn K., Mishina Y., Hanks M.C., Behringer R.R., Crenshaw E.B. BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development 2001, 128(22):4449-4461.
4. Aleshcheva G., Wehland M., Sahana J., Bauer J., Corydon T.J., Hemmersbach R., et al. Moderate alterations of the cytoskeleton in human chondrocytes after short-term microgravity produced by parabolic flight maneuvers could be prevented by up-regulation of BMP-2 and SOX-9. The FASEB Journal 2015, 29(6):2303-2314. 10.1096/fj.14-268151.
5. Ausk B.J., Huber P., Poliachik S.L., Bain S.D., Srinivasan S., Gross T.S. Cortical bone resorption following muscle paralysis is spatially heterogeneous. Bone 2012, 50(1):14-22. 10.1016/j.bone.2011.08.028.
6. Baldwin K.M. Effect of spaceflight on the functional, biochemical, and metabolic properties of skeletal muscle. Medicine and Science in Sports and Exercise 1996, 28(8):983-987.
7. Bandyopadhyay A., Tsuji K., Cox K., Harfe B.D., Rosen V., Tabin C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genetics 2006, 2(12):e216. 10.1371/journal.pgen.0020216.
8. Baron R., Rawadi G. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 2007, 148(6):2635-2643. 10.1210/en.2007-0270.
9. Battaglino R.A., Lazzari A.A., Garshick E., Morse L.R. Spinal cord injury-induced osteoporosis: Pathogenesis and emerging therapies. Current Osteoporosis Reports 2012, 10(4):278-285. 10.1007/s11914-012-0117-0.
10. Beederman M., Lamplot J., Nan G., Wang J., Liu X., Yin L., et al. BMP signaling in mesenchymal stem cell differentiation and bone formation. Journal of Biomedical Science and Engineering 2013, 6:32-52. 10.4236/jbise.2013.68A1004.
11. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423(6937):337-342. 10.1038/nature01658.
12. Brandi M.L., Collin-Osdoby P. Vascular biology and the skeleton. Journal of Bone and Mineral Research 2006, 21(2):183-192. 10.1359/JBMR.050917.
13. Briggs P.J., Moran C.G., Wood M.B. Actions of endothelin-1, 2, and 3 in the microvasculature of bone. Journal of Orthopaedic Research 1998, 16(3):340-347. 10.1002/jor.1100160310.
14. Buckey J.C., Lane L.D., Levine B.D., Watenpaugh D.E., Wright S.J., Moore W.E., et al. Orthostatic intolerance after spaceflight. Journal of Applied Physiology (Bethesda, Md.: 1985) 1996, 81(1):7-18.
15. Caillot-Augusseau A., Lafage-Proust M.H., Soler C., Pernod J., Dubois F., Alexandre C. Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95). Clinical Chemistry 1998, 44(3):578-585.
16. Canalis E. Mechanisms of glucocorticoid action in bone. Current Osteoporosis Reports 2005, 3(3):98-102.
17. Cao X.S., Yang L.J., Wu X.Y., Wu Y.H., Zhang L.N., Zhang L.F. Changes of bone morphogenesis proteins and transforming growth factor-beta in hind-limb bones of 21 d tail-suspended rats. Space Medicine & Medical Engineering (Beijing) 2003, 16(4):269-271.
18. Chen G., Deng C., Li Y.P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences 2012, 8(2):272-288. 10.7150/ijbs.2929.
19. Colleran P.N., Wilkerson M.K., Bloomfield S.A., Suva L.J., Turner R.T., Delp M.D. Alterations in skeletal perfusion with simulated microgravity: A possible mechanism for bone remodeling. Journal of Applied Physiology (Bethesda, Md.: 1985) 2000, 89(3):1046-1054.
20. Collet P., Uebelhart D., Vico L., Moro L., Hartmann D., Roth M., et al. Effects of 1- and 6-month spaceflight on bone mass and biochemistry in two humans. Bone 1997, 20(6):547-551.
21. Delp M.D., Colleran P.N., Wilkerson M.K., McCurdy M.R., Muller-Delp J. Structural and functional remodeling of skeletal muscle microvasculature is induced by simulated microgravity. American Journal of Physiology. Heart and Circulatory Physiology 2000, 278(6):H1866-H1873.
22. Dudas M., Sridurongrit S., Nagy A., Okazaki K., Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mechanisms of Development 2004, 121(2):173-182. 10.1016/j.mod.2003.12.003.
23. Edgerton V.R., Zhou M.Y., Ohira Y., Klitgaard H., Jiang B., Bell G., et al. Human fiber size and enzymatic properties after 5 and 11 days of spaceflight. Journal of Applied Physiology (Bethesda, Md.: 1985) 1995, 78(5):1733-1739.
24. Falahati-Nini A., Riggs B.L., Atkinson E.J., O'Fallon W.M., Eastell R., Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. The Journal of Clinical Investigation 2000, 106(12):1553-1560. 10.1172/JCI10942.
25. Farhat G.N., Cauley J.A. The link between osteoporosis and cardiovascular disease. Clinical Cases in Mineral and Bone Metabolism 2008, 5(1):19-34.
26. Fitts R.H., Riley D.R., Widrick J.J. Physiology of a microgravity environment invited review: Microgravity and skeletal muscle. Journal of Applied Physiology (Bethesda, Md.: 1985) 2000, 89(2):823-839.
27. Fritsch-Yelle J.M., Leuenberger U.A., D'Aunno D.S., Rossum A.C., Brown T.E., Wood M.L., et al. An episode of ventricular tachycardia during long-duration spaceflight. American Journal of Cardiology 1998, 81(11):1391-1392.
28. Gazenko O.G., Gurovsky N.N., Genin A.M., Bryanov I.I., Eryomin A.V., Egorov A.D. Results of medical investigations carried out on board the Salyut orbital stations. Life Sciences and Space Research 1976, 14:145-152.
29. Gazzerro E., Pereira R.C., Jorgetti V., Olson S., Economides A.N., Canalis E. Skeletal overexpression of gremlin impairs bone formation and causes osteopenia. Endocrinology 2005, 146(2):655-665. 10.1210/en.2004-0766.
30. Gazzerro E., Smerdel-Ramoya A., Zanotti S., Stadmeyer L., Durant D., Economides A.N., et al. Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. The Journal of Biological Chemistry 2007, 282(43):31549-31557. 10.1074/jbc.M701317200.
31. Geng Y., Dong Y., Yu M., Zhang L., Yan X., Sun J., et al. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(17):7058-7063. 10.1073/pnas.1007293108.
32. Gilbert S.F. Developmental Biology 2006, Sinauer, Sunderland, Massachusetts. 8 th ed.
33. Goode A.W., Rambaut P.C. The skeleton in space. Nature 1985, 317(6034):204-205.
34. Grigoriev A.I., Oganov V.S., Bakulin A.V., Poliakov V.V., Voronin L.I., Morgun V.V., et al. Clinical and physiological evaluation of bone changes among astronauts after long-term space flights. Aviakosmicheskaia i Ekologicheskaia Meditsina 1998, 32:21-25.
35. Gundel A., Polyakov V.V., Zulley J. The alteration of human sleep and circadian rhythms during spaceflight. Journal of Sleep Research 1997, 6(1):1-8.
36. Hargens A.R., Richardson S. Cardiovascular adaptations, fluid shifts, and countermeasures related to space flight. Respiratory Physiology & Neurobiology 2009, 169(Suppl. 1):S30-S33. 10.1016/j.resp.2009.07.005.
37. Hargens A.R., Watenpaugh D.E. Cardiovascular adaptation to spaceflight. Medicine and Science in Sports and Exercise 1996, 28(8):977-982.
38. Hillsley M.V., Frangos J.A. Bone tissue engineering: The role of interstitial fluid flow. Biotechnology and Bioengineering 1994, 43(7):573-581. 10.1002/bit.260430706.
39. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(16):9337-9342.
40. Inoue S., Nomura S., Hosoi T., Ouchi Y., Orimo H., Muramatsu M. Localization of follistatin, an activin-binding protein, in bone tissues. Calcified Tissue International 1994, 55(5):395-397.
41. Jain A.P., Pundir S., Sharma A. Bone morphogenetic proteins: The anomalous molecules. Journal of Indian Society of Periodontology 2013, 17(5):583-586. 10.4103/0972-124X.119275.
42. Jones A.R., Clark C.C., Brighton C.T. Microvessel endothelial cells and pericytes increase proliferation and repress osteoblast phenotypic markers in rat calvarial bone cell cultures. Journal of Orthopaedic Research 1995, 13(4):553-561. 10.1002/jor.1100130410.
43. Kanzler B., Foreman R.K., Labosky P.A., Mallo M. BMP signaling is essential for development of skeletogenic and neurogenic cranial neural crest. Development 2000, 127(5):1095-1104.
44. Keyak J.H., Koyama A.K., LeBlanc A., Lu Y., Lang T.F. Reduction in proximal femoral strength due to long-duration spaceflight. Bone 2009, 44(3):449-453. 10.1016/j.bone.2008.11.014.
45. Kokabu S., Gamer L., Cox K., Lowery J., Tsuji K., Raz R., et al. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Molecular Endocrinology 2012, 26(1):87-94. 10.1210/me.2011-1168.
46. Lang T., LeBlanc A., Evans H., Lu Y., Genant H., Yu A. Cortical and trabecular bone mineral loss from the spine and hip in long-duration spaceflight. Journal of Bone and Mineral Research 2004, 19(6):1006-1012. 10.1359/JBMR.040307.
47. Larrain J., Bachiller D., Lu B., Agius E., Piccolo S., De Robertis E.M. BMP-binding modules in chordin: A model for signalling regulation in the extracellular space. Development 2000, 127(4):821-830.
48. Leblanc A.D., Schneider V.S., Evans H.J., Engelbretson D.A., Krebs J.M. Bone mineral loss and recovery after 17 weeks of bed rest. Journal of Bone and Mineral Research 1990, 5(8):843-850. 10.1002/jbmr.5650050807.
49. Levine B.D., Zuckerman J.H., Pawelczyk J.A. Cardiac atrophy after bed-rest deconditioning: A nonneural mechanism for orthostatic intolerance. Circulation 1997, 96(2):517-525.
50. Li X., Ominsky M.S., Niu Q.T., Sun N., Daugherty B., D'Agostin D., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. Journal of Bone and Mineral Research 2008, 23(6):860-869. 10.1359/jbmr.080216.
51. Li X., Zhang Y., Kang H., Liu W., Liu P., Zhang J., et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. The Journal of Biological Chemistry 2005, 280(20):19883-19887. 10.1074/jbc.M413274200.
52. Luo J., Tang M., Huang J., He B.C., Gao J.L., Chen L., et al. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. The Journal of Biological Chemistry 2010, 285(38):29588-29598. 10.1074/jbc.M110.130518.
53. Majumder S., Siamwala J.H., Srinivasan S., Sinha S., Sridhara S.R.C., Soundararajan G., et al. Simulated microgravity promoted differentiation of bipotential murine oval liver stem cells by modulating BMP4/Notch1 signaling. Journal of Cellular Biochemistry 2011, 112:1898-1908.
54. McCarthy I.D. Fluid shifts due to microgravity and their effects on bone: A review of current knowledge. Annals of Biomedical Engineering 2005, 33(1):95-103.
55. McCarthy I. The physiology of bone blood flow: A review. Journal of Bone and Joint Surgery (American Volume) 2006, 88(Suppl. 3):4-9. 10.2106/jbjs.f.00890.
56. McCarthy I.D., Andhoga M., Batten J.J., Mathie R.T. Endothelium-dependent vasodilatation produced by the L-arginine/nitric oxide pathway in normal and ischemic bone. Acta Orthopaedica Scandinavica 1997, 68(4):361-368.
57. McMahon J.A., Takada S., Zimmerman L.B., Fan C.M., Harland R.M., McMahon A.P. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes & Development 1998, 12(10):1438-1452.
58. McPherron A.C., Lawler A.M., Lee S.J. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nature Genetics 1999, 22(3):260-264. 10.1038/10320.
59. Miyazono K., Maeda S., Imamura T. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine & Growth Factor Reviews 2005, 16:251-263.
60. Morey-Holton E.R., Globus R.K. Hindlimb unloading rodent model: Technical aspects. Journal of Applied Physiology (Bethesda, Md.: 1985) 2002, 92(4):1367-1377. 10.1152/japplphysiol.00969.2001.
61. Nabavi N., Khandani A., Camirand A., Harrison R.E. Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion. Bone 2011, 49(5):965-974. 10.1016/j.bone.2011.07.036.
62. Nguyen T.Q., Roestenberg P., van Nieuwenhoven F.A., Bovenschen N., Li Z., Xu L., et al. CTGF inhibits BMP-7 signaling in diabetic nephropathy. Journal of the American Society of Nephrology 2008, 19(11):2098-2107. 10.1681/ASN.2007111261.
63. Nie X., Luukko K., Kettunen P. BMP signalling in craniofacial development. The International Journal of Developmental Biology 2006, 50(6):511-521. 10.1387/ijdb.052101xn.
64. Nikaido M., Tada M., Saji T., Ueno N. Conservation of BMP signaling in zebrafish mesoderm patterning. Mechanisms of Development 1997, 61(1-2):75-88.
65. Oman C.M., Lichtenberg B.K., Money K.E., McCoy R.K. M.I.T./Canadian vestibular experiments on the Spacelab-1 mission: 4. Space motion sickness: Symptoms, stimuli, and predictability. Experimental Brain Research 1986, 64(2):316-334.
66. Papachroni K.K., Karatzas D.N., Papavassiliou K.A., Basdra E.K., Papavassiliou A.G. Mechanotransduction in osteoblast regulation and bone disease. Trends in Molecular Medicine 2009, 15:208-216.
67. Pappano W.N., Scott I.C., Clark T.G., Eddy R.L., Shows T.B., Greenspan D.S. Coding sequence and expression patterns of mouse chordin and mapping of the cognate mouse chrd and human CHRD genes. Genomics 1998, 52(2):236-239. 10.1006/geno.1998.5474.
68. Patel M.J., Chang K.H., Sykes M.C., Talish R., Rubin C., Jo H. Low magnitude and high frequency mechanical loading prevents decreased bone formation responses of 2T3 preosteoblasts. Journal of Cellular Biochemistry 2009, 106(2):306-316. 10.1002/jcb.22007.
69. Peng H., Usas A., Hannallah D., Olshanski A., Cooper G.M., Huard J. Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4. Molecular Therapy 2005, 12(2):239-246.
70. Prisby R.D., Behnke B.J., Allen M.R., Delp M.D. Effects of skeletal unloading on the vasomotor properties of the rat femur principal nutrient artery. Journal of Applied Physiology (Bethesda, Md.: 1985) 2015, 118:980-988. 10.1152/japplphysiol.00576.2014.
71. Qian X., Zhang C., Chen G., Tang Z., Liu Q., Chen J., et al. Effects of BMP-2 and FGF2 on the osteogenesis of bone marrow-derived mesenchymal stem cells in hindlimb-unloaded rats. Cell Biochemistry and Biophysics 2014, 70(2):1127-1136. 10.1007/s12013-014-0032-3.
72. Robling A.G., Niziolek P.J., Baldridge L.A., Condon K.W., Allen M.R., Alam I., et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. Journal of Biological Chemistry 2008, 283(9):5866-5875. 10.1074/jbc.M705092200.
73. Rucci N., Migliaccio S., Zani B.M., Taranta A., Teti A. Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved rotating wall vessel bioreactor (RWV). Journal of Cellular Biochemistry 2002, 85(1):167-179.
74. Safadi F.F., Xu J., Smock S.L., Kanaan R.A., Selim A.H., Odgren P.R., et al. Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. Journal of Cellular Physiology 2003, 196(1):51-62.
75. Sanchez C.P., He Y.Z. Bone growth during daily or intermittent calcitriol treatment during renal failure with advanced secondary hyperparathyroidism. Kidney International 2007, 72(5):582-591. 10.1038/sj.ki.5002375.
76. Sexton P.M., Findlay D.M., Martin T.J. Calcitonin. Current Medicinal Chemistry 1999, 6(11):1067-1093.
77. Shu B., Zhang M., Xie R., Wang M., Jin H., Hou W., et al. BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. Journal of Cell Science 2011, 124(Pt. 20):3428-3440. 10.1242/jcs.083659.
78. Siamwala J.H., Reddy S.H., Majumder S., Kolluru G.K., Muley A., Sinha S., et al. Simulated microgravity perturbs actin polymerization to promote nitric oxide associated migration in human immortalized Eahy926 cells. Protoplasma 2010, 242(1-4):3-12.
79. Siamwala J.H., Majumder S., Tamilarasan K.P., Muley A., Reddy S.H., Kolluru G.K., et al. Simulated microgravity promotes nitric oxide-supported angiogenesis via the iNOS-cGMP-PKG pathway in macrovascular endothelial cells. FEBS Letters, 4 2010, 584(15):3415-3423.
80. Siegel P.M., Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature Reviews. Cancer 2003, 3:807-821.
81. Sievanen H. Immobilization and bone structure in humans. Archives of Biochemistry and Biophysics 2010, 503(1):146-152. 10.1016/j.abb.2010.07.008.
82. Smith S.M., Wastney M.E., Morukov B.V., Larina I.M., Nyquist L.E., Abrams S.A., et al. Calcium metabolism before, during, and after a 3-mo spaceflight: Kinetic and biochemical changes. American Journal of Physiology 1999, 277(1 Pt. 2):R1-R10.
83. Stabley J.N., Prisby R.D., Behnke B.J., Delp M.D. Chronic skeletal unloading of the rat femur: Mechanisms and functional consequences of vascular remodeling. Bone 2013, 57(2):355-360. 10.1016/j.bone.2013.09.003.
84. Sylva M., Li V.S., Buffing A.A., van Es J.H., van den Born M., van der Velden S., et al. The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis. PloS One 2011, 6(8):e22616. 10.1371/journal.pone.0022616.
85. Tardif G., Pelletier J.P., Hum D., Boileau C., Duval N., Pelletier J.M. Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes. Annals of the Rheumatic Diseases 2006, 65(2):261-264.
86. Taylor G.R. Overview of spaceflight immunology studies. Journal of Leukocyte Biology 1993, 54(3):179-188.
87. Vico L., Collet P., Guignandon A., Lafage-Proust M.H., Thomas T., Rehaillia M., et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000, 355(9215):1607-1611.
88. Villanueva J.E., Nimni M.E. Promotion of calvarial cell osteogenesis by endothelial cells. Journal of Bone and Mineral Research 1990, 5(7):733-739. 10.1002/jbmr.5650050710.
89. Wang R.N., Green J., Wang Z., Deng Y., Qiao M., Peabody M., et al. Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes & Diseases 2014, 1(1):87-105. 10.1016/j.gendis.2014.07.005.
90. Wang B., Zhang S., Wu X.Y. Effects of BMP-2 on the gene expression of rat osteosarcoma cells under simulated weightlessness. Space Medicine & Medical Engineering (Beijing) 2004, 17(3):176-179.
91. Wang J., Zhou J., Cheng C.M., Kopchick J.J., Bondy C.A. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. The Journal of Endocrinology 2004, 180(2):247-255.
92. White R.J., Averner M. Humans in space. Nature 2001, 409(6823):1115-1118. 10.1038/35059243.
93. Wiater E., Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. The Journal of Biological Chemistry 2003, 278(10):7934-7941. 10.1074/jbc.M209710200.
94. Wilkerson M.K., Muller-Delp J., Colleran P.N., Delp M.D. Effects of hindlimb unloading on rat cerebral, splenic, and mesenteric resistance artery morphology. Journal of Applied Physiology (Bethesda, Md.: 1985) 1999, 87(6):2115-2121.
95. Worthley D.L., Churchill M., Compton J.T., Tailor Y., Rao M., Si Y., et al. Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell 2015, 160(1-2):269-284. 10.1016/j.cell.2014.11.042.
96. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988, 242(4885):1528-1534.
97. Wronski T.J., Morey E.R. Effect of spaceflight on periosteal bone formation in rats. American Journal of Physiology 1983, 244(3):R305-R309.
98. Yagodovsky V.S., Triftanidi L.A., Gorokhova G.P. Space flight effects on skeletal bones of rats (light and electron microscopic examination). Aviation, Space, and Environmental Medicine 1976, 47(7):734-738.
99. Yoshimura Y., Nomura S., Kawasaki S., Tsutsumimoto T., Shimizu T., Takaoka K. Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. Journal of Bone and Mineral Research 2001, 16(5):876-884.
100. Yu B., Zhao X., Yang C., Crane J., Xian L., Lu W., et al. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling. Journal of Bone and Mineral Research 2012, 27(9):2001-2014. 10.1002/jbmr.1663.
101. Zhang B., Cory E., Bhattacharya R., Sah R., Hargens A.R. Fifteen days of microgravity causes growth in calvaria of mice. Bone 2013, 56(2):290-295. 10.1016/j.bone.2013.06.009.
102. Zhou S., Turgeman G., Harris S.E., Leitman D.C., Komm B.S., Bodine P.V., et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Molecular Endocrinology 2003, 17(1):56-66. 10.1210/me.2002-0210.